4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-012647
Chief Executive Officer sold 4,548 shares at an average $202.15 ($919,374)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-05 | Sale : show line 1 in the form 10b5-1 | −1,840 | $200.44 | $368,806 | 565,468 | D |
| 2026-10-05 | Sale : show line 2 in the form 10b5-1 | −481 | $201.26 | $96,804 | 564,987 | D |
| 2026-10-05 | Sale : show line 3 in the form 10b5-1 | −1,017 | $202.32 | $205,763 | 563,970 | D |
| 2026-10-05 | Sale : show line 4 in the form 10b5-1 | −432 | $203.61 | $87,958 | 563,538 | D |
| 2026-10-05 | Sale : show line 5 in the form 10b5-1 | −290 | $204.80 | $59,392 | 563,248 | D |
| 2026-10-05 | Sale : show line 6 in the form 10b5-1 | −297 | $205.78 | $61,116 | 562,951 | D |
| 2026-10-05 | Sale : show line 7 in the form 10b5-1 | −146 | $206.84 | $30,199 | 562,805 | D |
| 2026-10-05 | Sale : show line 8 in the form 10b5-1 | −45 | $207.46 | $9,336 | 562,760 | D |
| Open-market sales · 4,548 sh · avg $202.15 · $919,374 | ||||||
Loading xslF345X06/marketforms-74107.xml…